This is a profile image of Franck Le Deu

Franck Le Deu

Senior PartnerHong Kong

Helps healthcare multinationals capture opportunities in China, Asia, and emerging markets, with a focus on improving commercial operations and business expansion

Based in Hong Kong, Franck is a leader of our Life Sciences Practice in China and works with companies across Asia on commercial topics. His main focus is marketing & sales strategy, including brand strategy, product launch, organization, and commercial transformation. Recent examples of Franck’s work include helping to create a growth strategy for the diabetes franchise of a multinational company; developing a growth strategy and sales and distribution model with a leading medical-device manufacturer; leading the turn-around of sales operations for a multinational pharmaceuticals company in China; assessing alternative business models in China; and developing a regional Asia strategy for a leading multinational.

Franck has also worked closely with senior clients on a number of high-profile mergers and acquisitions. He is a frequent speaker at leading industry conferences in China, including the BioCentury Healthcare Summit and the PhRMA Innovation Summit.

Published work

Vision 2028: How China could impact the global biopharma industry,” McKinsey & Company, August 2022

The dawn of China biopharma innovation,” McKinsey & Company, October 2021

Managing China’s growing oncology burden,” McKinsey & Company, August 2020

How COVID-19 is reshaping China’s medtech industry,” McKinsey & Company, May 2020

How COVID-19 changes the game for biopharma in China,” McKinsey & Company, April 2020

Biotech in Europe: A strong foundation for growth and innovation,” McKinsey & Company, August 2019

Biopharma in China: Insights into a market at a crossroads,” McKinsey & Company, May 2019

Asia on the move: Five trends shaping the Asia biopharmaceutical market,” McKinsey & Company, May 2018

MedTech in Asia: Committing at scale to raise standards of care for patients,” (PDF–4.88 MB), McKinsey & Company, December 2015

An essential strategy for the Essential Drug List,” McKinsey & Company, May 2015

Health care in China: Entering 'uncharted waters',” McKinsey & Company, November 2012

China's healthcare reform: Moving beyond reading of the tea leaves,” (PDF–767 KB), McKinsey & Company, 2010

“Seizing China's pharma opportunity,” McKinsey & Company, February 2008

Past experience

Ernst & Young
Corporate Finance/Audit
Senior manager

French Navy


Northwestern University, Kellogg School of Management

Ecole Superieure de Commerce de Nantes
MS, business administration